Mitsui & Co., Ltd. & Co, IHH Healthcare’s largest shareholder, said it is committed to continue executing the turnaround plan for Fortis Healthcare, while exploring further investments in the Indian healthcare sector.
IHH Healthcare acquired a 31% stake in Fortis Healthcare in August 2018 by paying $1.1 billion in a bidding process overseen by an independent board.
Three months after IHH Healthcare’s successful bid to acquire Fortis, its own shareholding underwent a significant change. Malaysian sovereign fund Khazanah Nasional Berhad, which was its largest shareholder, sold a 16 percent stake to existing investor Mitsui, making the Japanese trading company the biggest shareholder in IHH.
Mitsui now has a 32.9 percent shareholding in IHH Healthcare.
Mitsui’s other current investments in the Indian healthcare and pharmaceuticals market include Keimed, one of the largest pharma distributors in India, and GOQii, a smart preventive health platform.
